Skip to content
Georgia Commons
Menu

Official Code of Georgia Annotated

Title 31. HEALTH · Chapter 52. TERMINALLY ILL PATIENT’S RIGHT TO TRY INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES · Article 1. RIGHT TO TRY

31-52-4. Eligibility criteria.

Active

Current through: Including Acts of the 2025 Session of the General Assembly of Georgia.

  1. In order for a person to be considered an eligible patient to access an investigational drug, biological product, or device pursuant to this article, a physician must document in writing that the person:

  2. (1)

    Has a terminal illness;#

  3. (2)

    Has, in consultation with the physician, considered all other treatment options currently approved by the federal Food and Drug Administration;#

  4. (3)

    Has been given a recommendation by the physician for an investigational drug, biological product, or device; and#

  5. (4)

    Has given written informed consent for the use of the investigational drug, biological product, or device.#

The notes below are printed with the section but are not enacted law (O.C.G.A. § 1-1-1(c)). They are shown apart from the text.

History

Code 1981, § 31-52-4, enacted by Ga. L. 2016, p. 345, § 1/HB 34; Ga. L. 2025, p. 455, § 3/SB 72, effective July 1, 2025.

Amendments

The 2025 amendment, effective July 1, 2025, substituted “article” for “chapter” in the first sentence of this Code section.

Editor's notes

Ga. L. 2025, p. 455, § 1/SB 72, not codified by the General Assembly, provides: “This Act shall be known and may be cited as the ‘Hope for Georgia Patients Act.’”

Read the official page (the state's PDF, opened at the page this text was read from).

Current through: Including Acts of the 2025 Session of the General Assembly of Georgia.

Text read from t31-(v23)-2025-pdf.pdf, Volume V23, 2025 edition, pages 1088 to 1089; merge action: bound only; file SHA-256 ba5a57f85d04.